UPDATE 1-NORDIC STOCKS - Factors to watch on July 4
HELSINKI, July 4 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Thursday:
The Danish biotech firm said its collaborator, drug giant GlaxoSmithKline Plc's, would start a new phase 3 study of ofatumumab to treat pemphigus vulgaris, a rare autoimmune disorder of the skin. Ofatumumab, Genmab's only drug, is sold under the name Arzerra for the treatment of blood cancer.
- Radar showed missing plane may have turned back: Malaysia military
- Malaysian jetliner may have turned back before vanishing |
- Malaysian plane presumed crashed; questions over false IDs |
- Russian forces tighten grip on Crimea despite U.S. warning |